Polyketides as Secondary Metabolites from the Genus Aspergillus

Xuelian Bai, Sheng Yue, Zhen‐Xing Tang, Jingyi Pan, Shigui Wang, Bin Tang, Ting Zhou, Lu‐E Shi, Huawei ZhangJournal of Fungi 2023 · DOI

TL;DR

This review comprehensively catalogs the vast array of polyketides produced by Aspergillus fungi, detailing their chemical structures, biological activities, and biosynthetic pathways. It serves as a crucial resource for researchers seeking to understand and harness these compounds for pharmaceutical and industrial applications.

What Problem Does This Paper Address?

The genus Aspergillus is a prolific source of secondary metabolites (SMs), with over 3100 known compounds. Among these, polyketides are a particularly important class due to their diverse structures and wide range of biological properties, including antibiotic, immunosuppressant, and anticancer activities. However, a consolidated and comprehensive overview of Aspergillus-derived polyketides, their structures, bioactivities, and biosynthetic origins, has been lacking. This review aims to fill that gap by systematically compiling and summarizing the existing knowledge on these compounds, providing a valuable reference for researchers in mycology, natural product chemistry, and drug discovery.

Methods

This paper is a comprehensive review based on an extensive literature search and data analysis. The authors systematically collected information on Aspergillus-derived polyketides from various scientific databases and publications. They then categorized these compounds based on their structural features, including benzophenones, diphenyl ethers, furans and furanones, isocoumarins, lignans, naphthalenes, phenolics, polyenes, pyrans and pyranones, quinones, steroids, meroterpenoids, and xanthones. For each compound or class, the review details their occurrences, chemical structures, known bioactivities, and proposed biosynthetic pathways.

Datasets

Not discussed in the paper. The paper is a review article based on existing literature.

Key Insights and Ideas

  • Aspergillus as a Polyketide Powerhouse: The review highlights Aspergillus species as exceptionally rich sources of diverse and biologically active polyketides, underscoring their significance in natural product discovery.
  • Structural Diversity is Key: The sheer variety of polyketide structures isolated from Aspergillus (e.g., benzophenones, furanones, anthraquinones) points to the complex and adaptable biosynthetic machinery within these fungi.
  • Therapeutic Potential is Vast: Many Aspergillus-derived polyketides exhibit promising bioactivities, including antimicrobial, anti-inflammatory, cytotoxic, and enzyme-inhibitory effects, suggesting their potential for drug development.
  • Biosynthetic Pathways Offer Clues: Understanding the proposed biosynthetic pathways provides insights into how these complex molecules are assembled, which is crucial for future engineering and discovery efforts.
  • The "Silent" Genome Challenge: The review implicitly points to the vast untapped potential within Aspergillus genomes, as many polyketide biosynthetic gene clusters remain "silent" or uncharacterized under standard laboratory conditions, hinting at future discovery avenues.

Key Results

The review comprehensively lists and describes 343 Aspergillus-derived polyketide derivatives. These compounds are categorized into fourteen major structural classes. Specific examples of bioactivities are provided, such as:

  • Prenylated benzophenone pre-shamixanthone (1) showing significant inhibition of lipid accumulation and reduction of total cholesterol and triglycerides.
  • Dichlorinated benzophenones (2, 3) with potential as immunosuppressants.
  • Diphenyl ethers (e.g., 25) exhibiting stronger α-glucosidase inhibitory effects than acarbose.
  • Furanones and benzofuranones (e.g., penicillic acid) acting as important antibiotic agents.
  • Anthraquinones (e.g., 230, 231) showing potent cytotoxicities and inhibitory effects on receptor tyrosine kinases.
  • Steroids (e.g., ergosterol) exhibiting anticancer activities.

Limitations and Future Work

The authors acknowledge that the review is based on existing literature up to the end of 2022. They suggest that the potential for discovering novel polyketides from Aspergillus is immense, especially considering that many polyketide biosynthetic gene clusters (BGCs) are inactive under traditional culture conditions. Future work should focus on:

  • Bioinformatics and Analytical Techniques: Utilizing advanced tools to explore Aspergillus genomes and identify functional genes.
  • "Silent" BGC Activation: Employing strategies like the One Strain Many Compounds (OSMAC) approach and genome mining combined with metabolic engineering to activate and characterize these silent BGCs.
  • Biosynthetic Engineering: Understanding the structural features of polyketide synthases (PKSs) to enable rational design and engineering of novel polyketides.
  • Improving Discovery Efficiency: Developing biosynthetic engineering approaches to enhance the efficient discovery of new polyketides from the Aspergillus genus.

Summary updated

Abstract

Polyketides are an important class of structurally diverse natural products derived from a precursor molecule consisting of a chain of alternating ketone and methylene groups. These compounds have attracted the worldwide attention of pharmaceutical researchers since they are endowed with a wide array of biological properties. As one of the most common filamentous fungi in nature, <i>Aspergillus</i> spp. is well known as an excellent producer of polyketide compounds with therapeutic potential. By extensive literature search and data analysis, this review comprehensively summarizes <i>Aspergillus</i>-derived polyketides for the first time, regarding their occurrences, chemical structures and bioactivities as well as biosynthetic logics.
BibTeX
@article{bai2023polyketides,
  author = {Xuelian Bai and Sheng Yue and Zhen‐Xing Tang and Jingyi Pan and Shigui Wang and Bin Tang and Ting Zhou and Lu‐E Shi and Huawei Zhang},
  title = {{Polyketides as Secondary Metabolites from the Genus Aspergillus}},
  journal = {Journal of Fungi},
  year = {2023},
  doi = {10.3390/jof9020261},
}
Figure